Crossmark

Reduction of fatigue and anger-hostility by the oral administration of 5-aminolevulinic acid phosphate: a randomized, double-blind, placebo-controlled, parallel study

Crossref DOI link: https://doi.org/10.1038/s41598-020-72763-4

Published Online: 2020-09-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Higashikawa, Fumiko

Kanno, Keishi

Ogata, Akiko

Sugiyama, Masanori
Funding

Funding for this research was provided by:

ALApromo Co., Ltd., Tokyo, Japan
License Information

Text and Data Mining valid from 2020-09-29

Version of Record valid from 2020-09-29
More Information

Article History

Received: 8 January 2020

Accepted: 30 August 2020

First Online: 29 September 2020

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below